Drug intelligence / Profile preview

5-grass pollen extract

Development stage
Unknown
Lead developer
Stallergenes Greer
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual
01

Overview

5-grass pollen extract is an allergen immunotherapy (AIT) product developed by Probelte Pharma, containing a standardized mixture of extracts from five common grasses: *Dactylis glomerata* (Orchard grass), *Festuca pratensis* (Meadow fescue), *Lolium perenne* (Perennial ryegrass), *Phleum pratense* (Timothy grass), and *Poa pratensis* (Kentucky bluegrass). The therapy is indicated for the treatment of allergic rhinitis, allergic conjunctivitis, and controlled allergic asthma in patients with IgE-mediated hypersensitivity to grass pollens. Its mechanism of action involves the induction of immune tolerance by shifting the immune response from a Th2-dominated profile to a Th1-dominated profile, stimulating the expansion of regulatory T cells (Tregs), and increasing the production of allergen-specific IgG4 antibodies. These IgG4 antibodies act as blocking antibodies that compete with IgE for allergen binding, thereby preventing mast cell degranulation and the subsequent release of inflammatory mediators. The product is available in both subcutaneous (often adsorbed on aluminum hydroxide) and sublingual formulations.

Brand names
AlergolAlergol DepotAlergol Sublingual
Other names
allergen extract of grass pollen mixture (dactylis glomerata + festuca pratensis + lolium perenne + phleum pratense + poa pratensis)5-grass mixtureMix 5 GrassesMix5 GrassesMix-5 Grasses
02

Targets

IL10 (Interleukin-10)IL-4 (Interleukin 4)IFNG (Interferon gamma)sIgG4 (Allergen-specific immunoglobulin G4)

Beyond the preview

Go deeper on 5-grass pollen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-grass pollen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call